Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials-Reference-Cited by-同舟云学术

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

Published:2010-11 Issue:50 Volume:28 Page:7993-8000
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Torresi Joseph,McCarthy Karen,Feroldi Emmanuel,Méric Claude

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998;Tsai;Vaccine,2000

2. Japanese encephalitis vaccines;World Health Organization;Wkly Epidemiol Rec,2006

3. Japanese encephalitis vaccine;Halstead,2004

4. Vaccination against Japanese encephalitis in the Torres Straight;Hanna;Commun Dis Intel,1996

5. Protection against Japanese encephalitis by inactivated vaccines;Hoke;N Engl J Med,1988

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trial;Vaccine;2024-12

2. Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview;Heliyon;2024-08

3. Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development;Viruses;2023-03-23

4. Japanese Encephalitis Vaccines;Plotkin's Vaccines;2023

5. Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine;Journal of Travel Medicine;2022-10-29